Biotech Values

[DewDiligence]

TEVA—When asked about the 2015 sales and earnings guidance of $31B and $6.8B respectively, Yanai said it's the goal they are aiming to but then he added a few more sentences that surely sounded like a he doesn't think it's possible.

I heard it. It was not one of Yanai’s finer moments, and such doubletalk is (IMO) counter-productive to the goal of regaining respect on Wall Street.